News
Ista reports positive results from Phase IIb dry eye trial Pharmaceutical Business Review
View ArticleNews
EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrome Medical News Today
View ArticleOphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3...
OphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study Yahoo/PR Newswire
View ArticleFor Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy?
For Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy? Motley Fool
View ArticleAllergan pushes FDA to defend Restasis from early generics
Allergan pushes FDA to defend Restasis from early generics Fierce Pharma
View ArticleShire's new dry eye drug disappoints in pivotal trial
Shire's new dry eye drug disappoints in pivotal trial Yahoo/Reuters
View ArticleOphthaliX’s dry eye drug fails endpoint in Phase III study
OphthaliX’s dry eye drug fails endpoint in Phase III study Pharmaceutical Business Review
View ArticleThird Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program
Third Rock's Eleven pitches a $69M IPO to fuel its PhIII dry eye program Fierce Biotech
View ArticleAllergan Slips on Restasis Challenge
Allergan Slips on Restasis Challenge Yahoo/Zacks.com
View ArticleShire says new dry-eye drug fails to meet trial goal
Shire says new dry-eye drug fails to meet trial goal Yahoo/Reuters
View ArticleShire to submit dry eye treatment to U.S. drug regulator
Shire to submit dry eye treatment to U.S. drug regulator Yahoo/Reuters
View ArticleRegeneRx’s Strategic Partner G-treeBNT Preparing for Phase III Dry Eye Trials...
RegeneRx’s Strategic Partner G-treeBNT Preparing for Phase III Dry Eye Trials in Asia with RGN-259 Yahoo
View Article
